Skip to content

Avanos Medical AVNS Finite-Lived Intangible Assets, Accumulated Amortization

Finite-Lived Intangible Assets, Accumulated Amortization at other companies

Cardinal Health logo
Cardinal HealthCAH
Boston Scientific logo
Boston ScientificBSX
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
Medtronic logo
MedtronicMDT
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
IAR
Integra LifeSciencesIART

Other financials

Income statement

See full
Revenue$182.2M+8.8%
Gross profit$94.2M+4.9%
Operating income$8.9M-13.6%
Net income$5.1M-22.7%
EPS (diluted)$0.11-21.4%

Balance sheet

See full
Cash & equivalents$65.6M-32.4%
Total debt$138.4M-1.8%
Total equity$782.1M-6.8%
Total assets$1.1B-5.2%

Cash flow

See full
Operating cash flow-$12.3M-148%
CapEx$4.3M-35.8%
Free cash flow-$16.6M-187%

Valuation

See full
Market cap$1.17B+108%
Enterprise value$1.24B+105%
P/S1.6×+0.8×

Profitability

See full
Gross margin50%-4.6pp
Operating margin-9.1%-4.2pp
Net margin-10.4%-4.7pp
FCF margin1.6%-14.9pp

Returns & leverage

See full
Return on equity-9.2%-3.9pp
Debt / equity0.2×0.0×
Current ratio2.5×-0.1×

Where this comes from

Reported directly by Avanos Medical in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.

The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Avanos Medical's finite-lived intangible assets, accumulated amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Avanos Medical's finite-lived intangible assets, accumulated amortization?
Avanos Medical (AVNS) reported finite-lived intangible assets, accumulated amortization of $274.5M in Q1 2026.
How has Avanos Medical's finite-lived intangible assets, accumulated amortization changed year-over-year?
Avanos Medical's finite-lived intangible assets, accumulated amortization increased by 71.1% year-over-year, from $160.4M to $274.5M.
What is the long-term trend for Avanos Medical's finite-lived intangible assets, accumulated amortization?
Over 5 years (2020 to 2025), Avanos Medical's finite-lived intangible assets, accumulated amortization has grown at a -0.5% compound annual growth rate (CAGR), from $276.6M to $270.1M.